WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that Drug Safety Alliance, Inc. (DSA) has updated and implemented Phase Forward’s Web-based adverse event tracking and reporting system, Clintrace™ 4.1. The successful update required data migration and validation of more than 21,000 cases on behalf of 25 DSA clients.
